530199 Stock Overview
Themis Medicare Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India and internationally.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 2/6 |
Financial Health | 5/6 |
Dividends | 1/6 |
Rewards
Risk Analysis
No risks detected for 530199 from our risk checks.
Themis Medicare Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₹222.35 |
52 Week High | ₹266.00 |
52 Week Low | ₹109.00 |
Beta | 0.61 |
1 Month Change | -9.24% |
3 Month Change | 7.49% |
1 Year Change | 95.88% |
3 Year Change | 693.26% |
5 Year Change | 679.77% |
Change since IPO | 10,029.84% |
Recent News & Updates
Recent updates
Shareholder Returns
530199 | IN Pharmaceuticals | IN Market | |
---|---|---|---|
7D | 7.8% | 2.7% | 2.5% |
1Y | 95.9% | 63.9% | 47.3% |
Return vs Industry: 530199 exceeded the Indian Pharmaceuticals industry which returned 65% over the past year.
Return vs Market: 530199 exceeded the Indian Market which returned 48.6% over the past year.
Price Volatility
530199 volatility | |
---|---|
530199 Average Weekly Movement | 7.1% |
Pharmaceuticals Industry Average Movement | 5.9% |
Market Average Movement | 6.6% |
10% most volatile stocks in IN Market | 10.1% |
10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 530199 has not had significant price volatility in the past 3 months.
Volatility Over Time: 530199's weekly volatility (7%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1952 | 996 | Sachin Patel | https://www.themismedicare.com |
Themis Medicare Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India and internationally. It offers active pharmaceutical ingredients (APIs) and formulations for use in various therapeutic areas, including anti-tuberculosis, anti-malarials, cardiology, pain management, anti-infectives, haematinics, health and nutrition, anaesthesia, gynecology, and orthopedics, as well as non-steroidal anti-inflammatory drugs. The company was formerly known as Themis Chemicals and changed its name to Themis Medicare Limited in 2001.
Themis Medicare Limited Fundamentals Summary
530199 fundamental statistics | |
---|---|
Market cap | ₹20.47b |
Earnings (TTM) | ₹452.86m |
Revenue (TTM) | ₹3.64b |
45.2x
P/E Ratio5.6x
P/S RatioIs 530199 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
530199 income statement (TTM) | |
---|---|
Revenue | ₹3.64b |
Cost of Revenue | ₹1.28b |
Gross Profit | ₹2.36b |
Other Expenses | ₹1.91b |
Earnings | ₹452.86m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 30, 2024
Earnings per share (EPS) | 4.92 |
Gross Margin | 64.89% |
Net Profit Margin | 12.44% |
Debt/Equity Ratio | 26.0% |
How did 530199 perform over the long term?
See historical performance and comparison